CVS Health (NYSE:CVS) issued an update on its FY20 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $7.04-7.17 for the period, compared to the Thomson Reuters consensus estimate of $7.15. CVS Health also updated its FY 2020
Pre-Market guidance to 7.04-7.17 EPS.

NYSE CVS traded down $0.63 during trading hours on Friday, hitting $71.37. 7,652,732 shares of the company’s stock traded hands, compared to its average volume of 7,157,139. CVS Health has a 52-week low of $51.72 and a 52-week high of $77.03. The company has a market capitalization of $95.30 billion, a PE ratio of 21.12, a PEG ratio of 1.56 and a beta of 0.93. The company has a debt-to-equity ratio of 1.32, a current ratio of 0.92 and a quick ratio of 0.61. The firm’s 50-day moving average is $72.71 and its 200-day moving average is $67.58.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.68 by $0.05. CVS Health had a net margin of 1.83% and a return on equity of 15.45%. The company had revenue of $66.89 billion during the quarter, compared to analysts’ expectations of $64.01 billion. During the same quarter in the prior year, the company earned $2.14 EPS. CVS Health’s revenue was up 22.9% compared to the same quarter last year. Equities research analysts predict that CVS Health will post 7.03 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.50 dividend. The ex-dividend date was Wednesday, January 22nd. This represents a $2.00 annualized dividend and a dividend yield of 2.80%. CVS Health’s dividend payout ratio (DPR) is 28.25%.

Several analysts have recently weighed in on CVS shares. Cowen set a $76.00 price target on shares of CVS Health and gave the company a buy rating in a research note on Monday, October 21st. Cfra increased their price target on shares of CVS Health from $85.00 to $86.00 and gave the company a strong-buy rating in a research note on Wednesday. Citigroup increased their price target on shares of CVS Health from $83.00 to $86.00 and gave the company a buy rating in a research note on Friday. SunTrust Banks increased their price target on shares of CVS Health to $85.00 and gave the company a buy rating in a research note on Thursday, November 7th. Finally, Oppenheimer started coverage on shares of CVS Health in a research note on Wednesday. They issued a hold rating for the company. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of $78.48.

In other news, EVP Karen S. Lynch sold 80,143 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $6,010,725.00. Following the transaction, the executive vice president now directly owns 41,831 shares in the company, valued at approximately $3,137,325. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Larry J. Merlo sold 266,476 shares of the company’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $74.79, for a total transaction of $19,929,740.04. Following the completion of the transaction, the chief executive officer now owns 703,497 shares in the company, valued at $52,614,540.63. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 404,182 shares of company stock worth $30,121,266. Company insiders own 0.53% of the company’s stock.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Article: Swap

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.